(Q40415626)

20 September 2017

Adult growth hormone replacement therapy and neuroimaging surveillance in brain tumour survivors (English)

1 reference

Hormone Replacement Therapy

20 September 2017

0 references

1 reference

Andreas Jostel

1

1 reference

20 September 2017

Annice Mukherjee

series ordinal

2

1 reference

20 September 2017

Paul A Hulse

series ordinal

3

1 reference

20 September 2017

Stephen M Shalet

series ordinal

4

1 reference

20 September 2017

1 June 2005

1 reference

20 September 2017

Clinical Endocrinology

1 reference

20 September 2017

62

1 reference

20 September 2017

6

1 reference

20 September 2017

698-705

1 reference

Does growth hormone cause relapse of brain tumours?

20 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02282.X

Growth hormone treatment of children with brain tumors and risk of tumor recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02282.X

The Growth Hormone Research Society consensus guidelines for the diagnosis and treatment of adult GH deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02282.X

Hypothalamo-pituitary surveillance imaging in hypopituitary patients receiving long-term GH replacement therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02282.X

GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02282.X

Effect of growth hormone (GH) treatment on bone in postpubertal GH-deficient patients: a 2-year randomized, controlled, dose-ranging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02282.X

Second neoplasms after megavoltage radiation for pediatric tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02282.X

Radiation-induced meningiomas involving the orbit

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02282.X

Tumors and other diseases following childhood x-ray treatment for ringworm of the scalp (Tinea capitis).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02282.X

Radiation-induced meningioma with a long latency period: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02282.X

Atypical tentorial meningioma 30 years after radiotherapy for a pituitary adenoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02282.X

Does GH replacement therapy in adult GH-deficient patients result in recurrence or increase in size of pituitary tumours?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02282.X

Medical and neurocognitive late effects among survivors of childhood central nervous system tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02282.X

Tumor- and treatment-related side effects after multimodal therapy of childhood intracranial germ cell tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02282.X

Chronic neuroendocrinological sequelae of radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02282.X

Effect of cancer therapy on pituitary-testicular axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02282.X

Three- and four-year cognitive outcome in children with noncortical brain tumors treated with whole-brain radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02282.X

The neurodevelopmental price of survival in children with malignant brain tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02282.X

High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02282.X

Primitive neuroectodermal tumors in the central nervous system following cranial irradiation: a report of four cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02282.X

Insulin-like growth factor I receptor signalling in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02282.X

Insulin-like growth factor I stimulates angiogenesis and the production of vascular endothelial growth factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02282.X

Regulation of proliferation and apoptosis by the insulin-like growth factor I receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02282.X

Insulin-like growth factor physiology and neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02282.X

Oncological complications of excess GH in acromegaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02282.X

Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02282.X

Insulin-like growth factor I (IGF-I), IGF-binding protein-3 and prostate cancer risk: epidemiological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02282.X

Acromegaly and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02282.X

Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02282.X

Potential adverse effects of long-term testosterone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02282.X

Risks of testosterone-replacement therapy and recommendations for monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02282.X

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02282.X

Growth hormone (GH) replacement therapy: cancer in adults treated with GH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02282.X

Long-term experience with GH replacement therapy: efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02282.X

Improvements in final height over 25 years in growth hormone (GH)-deficient childhood survivors of brain tumors receiving GH replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02282.X

Influences on quality of life in GH deficient adults and their effect on response to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02282.X

Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two year study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02282.X

Human growth hormone replacement in adult hypopituitary patients: long-term effects on body composition and lipid status--3-year results from the HypoCCS Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02282.X

Low-dose GH replacement improves the adverse lipid profile associated with the adult GH deficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02282.X

Effects of GH replacement on endothelial function and large-artery stiffness in GH-deficient adults: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02282.X

10.1111/J.1365-2265.2005.02282.X

21 January 2018

Identifiers

DOI

1 reference

20 September 2017

1 reference